Procurement of lateral flow cassettes for the rapid HIV nucleic acid diagnostic test
Closed Solicitation Posted
- Solicitation number
- 2026-Q-99143
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Place of performance
- Atlanta, Georgia 30341, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention seeks 2,000 lateral flow cassettes with supporting plastic consumables for rapid HIV nucleic acid diagnostic testing, with proposals due August 18 at 2:00 PM EDT and questions due August 7. This is an RFQ (75D301-26-Q-79168) issued as a combined synopsis and solicitation; no small business set-aside applies and competition is unrestricted.
Place of performance is the CDC's Chamblee Campus facility in Atlanta, Georgia. The contractor must design and produce lateral flow cassettes, lateral flow strips, and reaction tubes to meet specific technical requirements: RNase- and DNase-free reaction tubes suitable for LAMP reactions; locking caps to prevent tube reopening; seamless interface between reaction tube and cassette allowing irreversible attachment and leak-free transfer of contents; environmental contamination prevention through encapsulation of amplified material; and reproducible results. The NAICS code is 334516, Analytical Laboratory Instrument Manufacturing; PSC is 6550, In Vitro Diagnostic Substances, Reagents, Test Kits and Sets.
Performance runs from September 1, 2026 through December 31, 2027 on a firm fixed-price basis. The contractor shall deliver 100 prototype units by month seven for CDC evaluation, followed by 2,000 final units by month fourteen. Task requirements include bi-weekly technical meetings, Design History File documentation, final design specifications with CAD files suitable for cost-effective mass production, and Section 508 accessibility compliance. Evaluation weighs technical factors—vendor's design plan and three case studies of similar complexity from the past five years—as significantly more important than price. Award is based on best value and comprehensive cost analysis. Contact Debra A. Baker at xvv9@cdc.gov or 404-498-4855.
Notice text
This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with the format in subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
Solicitation number 75D301-26-Q-79168 is issued as a request for quote (RFQ).
This acquisition is not set-aside for small business concerns.
Files
| File | Type | Posted |
|---|---|---|
| REQUEST FOR QUOTATIONS-75D301-26-Q-79168.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Early infant diagnosis (EID) test kits and related reagents and consumables | Department of State | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity